Xiaoshan Li

2.5k citations
75 papers · 1.7k indexed · 1 hit paper · h-index 20
Topics
COVID-19 and Mental Health (8 papers)HIV Research and Treatment (8 papers)HIV/AIDS Research and Interventions (7 papers)

In The Last Decade

Xiaoshan Li

64 papers receiving 1.6k citations

Hit Papers

Mental health consequences of COVID-19 media coverage: th...2021202620222024202150100150200250

Peers

Xiaoshan Li
Comparison fields: 5 of 170
  • Infectious Diseases 419
  • Sociology and Political Science 375
  • Epidemiology 291
  • Clinical Psychology 256
  • Virology 217
Replace Shujuan Yang with:
Shujuan Yang China
Jeffrey Kahn United States
Nguyễn Văn Huy Vietnam
Ran Hu China
Andrea Brambilla Italy
Guangyu Zhou China
Chen Zhang China
Mahesh Choolani Singapore
Xiaoshan Li relative to Shujuan Yang China Shujuan Yang's profile →
Citations per field
00.5×2.8×
Shujuan Yang · 1×
Citations per year

Countries citing papers authored by Xiaoshan Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoshan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoshan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoshan Li more than expected).

Fields of papers citing papers by Xiaoshan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoshan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoshan Li. The network helps show where Xiaoshan Li may publish in the future.

Co-authorship network of co-authors of Xiaoshan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoshan Li. A scholar is included among the top collaborators of Xiaoshan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoshan Li. Xiaoshan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 6
5 0
6 0
7 2
8 1
9 2
10 9
11 3
12 5
13 12
14 70
15 1
16 2
17 14
18 40
19 28
20
d-bar equation on a lunar domain with mixed boundary conditions
1

About Xiaoshan Li

Xiaoshan Li is a scholar working on Virology, Transplantation and Health, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include COVID-19 and Mental Health (8 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). The work is most often cited by research in Virology (217 citations), Infectious Diseases (419 citations) and Modeling and Simulation (97 citations). Xiaoshan Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhaohui Su, Dean McDonnell, Ali Cheshmehzangi, Sabina Šegalo, Junaid Aḥmad, Jaffar Abbas, Yuyang Cai, Yu‐Tao Xiang, Jun Wen and Ling Yang. Their work appears in journals such as PLoS ONE, Chemical Communications and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026